These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30065346)

  • 1. L-tyrosine supplementation does not ameliorate skeletal muscle dysfunction in zebrafish and mouse models of dominant skeletal muscle α-actin nemaline myopathy.
    Messineo AM; Gineste C; Sztal TE; McNamara EL; Vilmen C; Ogier AC; Hahne D; Bendahan D; Laing NG; Bryson-Richardson RJ; Gondin J; Nowak KJ
    Sci Rep; 2018 Jul; 8(1):11490. PubMed ID: 30065346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression.
    Ravenscroft G; Jackaman C; Sewry CA; McNamara E; Squire SE; Potter AC; Papadimitriou J; Griffiths LM; Bakker AJ; Davies KE; Laing NG; Nowak KJ
    PLoS One; 2011; 6(12):e28699. PubMed ID: 22174871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy.
    Nguyen MA; Joya JE; Kee AJ; Domazetovska A; Yang N; Hook JW; Lemckert FA; Kettle E; Valova VA; Robinson PJ; North KN; Gunning PW; Mitchell CA; Hardeman EC
    Brain; 2011 Dec; 134(Pt 12):3516-29. PubMed ID: 22067542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined MRI and ³¹P-MRS investigations of the ACTA1(H40Y) mouse model of nemaline myopathy show impaired muscle function and altered energy metabolism.
    Gineste C; Le Fur Y; Vilmen C; Le Troter A; Pecchi E; Cozzone PJ; Hardeman EC; Bendahan D; Gondin J
    PLoS One; 2013; 8(4):e61517. PubMed ID: 23613869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial Biology.
    Tinklenberg JA; Slick RA; Sutton J; Zhang L; Meng H; Beatka MJ; Vanden Avond M; Prom MJ; Ott E; Montanaro F; Heisner J; Toro R; Hardeman EC; Geurts AM; Stowe DF; Hill RB; Lawlor MW
    Am J Pathol; 2023 Oct; 193(10):1548-1567. PubMed ID: 37419385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.
    Gineste C; Duhamel G; Le Fur Y; Vilmen C; Cozzone PJ; Nowak KJ; Bendahan D; Gondin J
    PLoS One; 2013; 8(8):e72294. PubMed ID: 23977274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function.
    Sztal TE; Zhao M; Williams C; Oorschot V; Parslow AC; Giousoh A; Yuen M; Hall TE; Costin A; Ramm G; Bird PI; Busch-Nentwich EM; Stemple DL; Currie PD; Cooper ST; Laing NG; Nowak KJ; Bryson-Richardson RJ
    Acta Neuropathol; 2015 Sep; 130(3):389-406. PubMed ID: 25931053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies.
    Ravenscroft G; Jackaman C; Bringans S; Papadimitriou JM; Griffiths LM; McNamara E; Bakker AJ; Davies KE; Laing NG; Nowak KJ
    Brain; 2011 Apr; 134(Pt 4):1101-15. PubMed ID: 21303860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary L-tyrosine supplementation in nemaline myopathy.
    Ryan MM; Sy C; Rudge S; Ellaway C; Ketteridge D; Roddick LG; Iannaccone ST; Kornberg AJ; North KN
    J Child Neurol; 2008 Jun; 23(6):609-13. PubMed ID: 18079309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining alpha-skeletal and alpha-cardiac actin expression in human heart and skeletal muscle explains the absence of cardiac involvement in ACTA1 nemaline myopathy.
    Ilkovski B; Clement S; Sewry C; North KN; Cooper ST
    Neuromuscul Disord; 2005 Dec; 15(12):829-35. PubMed ID: 16288873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac α-actin over-expression therapy in dominant ACTA1 disease.
    Ravenscroft G; McNamara E; Griffiths LM; Papadimitriou JM; Hardeman EC; Bakker AJ; Davies KE; Laing NG; Nowak KJ
    Hum Mol Genet; 2013 Oct; 22(19):3987-97. PubMed ID: 23736297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice.
    Tinklenberg JA; Siebers EM; Beatka MJ; Meng H; Yang L; Zhang Z; Ross JA; Ochala J; Morris C; Owens JM; Laing NG; Nowak KJ; Lawlor MW
    Hum Mol Genet; 2018 Feb; 27(4):638-648. PubMed ID: 29293963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nemaline myopathy caused by absence of alpha-skeletal muscle actin.
    Nowak KJ; Sewry CA; Navarro C; Squier W; Reina C; Ricoy JR; Jayawant SS; Childs AM; Dobbie JA; Appleton RE; Mountford RC; Walker KR; Clement S; Barois A; Muntoni F; Romero NB; Laing NG
    Ann Neurol; 2007 Feb; 61(2):175-84. PubMed ID: 17187373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe nemaline myopathy caused by mutations of the stop codon of the skeletal muscle alpha actin gene (ACTA1).
    Wallefeld W; Krause S; Nowak KJ; Dye D; Horváth R; Molnár Z; Szabó M; Hashimoto K; Reina C; De Carlos J; Rosell J; Cabello A; Navarro C; Nishino I; Lochmüller H; Laing NG
    Neuromuscul Disord; 2006 Oct; 16(9-10):541-7. PubMed ID: 16945536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.
    Tinklenberg J; Meng H; Yang L; Liu F; Hoffmann RG; Dasgupta M; Allen KP; Beggs AH; Hardeman EC; Pearsall RS; Fitts RH; Lawlor MW
    Am J Pathol; 2016 Jun; 186(6):1568-81. PubMed ID: 27102768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nemaline myopathy-related skeletal muscle α-actin (ACTA1) mutation, Asp286Gly, prevents proper strong myosin binding and triggers muscle weakness.
    Ochala J; Ravenscroft G; Laing NG; Nowak KJ
    PLoS One; 2012; 7(9):e45923. PubMed ID: 23029319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations.
    Agrawal PB; Strickland CD; Midgett C; Morales A; Newburger DE; Poulos MA; Tomczak KK; Ryan MM; Iannaccone ST; Crawford TO; Laing NG; Beggs AH
    Ann Neurol; 2004 Jul; 56(1):86-96. PubMed ID: 15236405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic tirasemtiv treatment improves in vivo and in vitro muscle performance in actin-based nemaline myopathy mice.
    de Winter JM; Gineste C; Minardi E; Brocca L; Rossi M; Borsboom T; Beggs AH; Bernard M; Bendahan D; Hwee DT; Malik FI; Pellegrino MA; Bottinelli R; Gondin J; Ottenheijm CAC
    Hum Mol Genet; 2021 Jun; 30(14):1305-1320. PubMed ID: 33909041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and functional alterations of neuromuscular synapses in a mouse model of ACTA1 congenital myopathy.
    Liu Y; Lin W
    Hum Mol Genet; 2024 Jan; 33(3):233-244. PubMed ID: 37883471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic progression and a novel mutation in a child with nemaline myopathy.
    Ladha S; Coons S; Johnsen S; Sambuughin N; Bien-Wilner R; Sivakumar K
    J Child Neurol; 2008 Jul; 23(7):813-7. PubMed ID: 18487519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.